(−)-Epigallocatechin-3-Gallate and Quercetin Inhibit Quiescin Sulfhydryl Oxidase 1 Secretion from Hepatocellular Carcinoma Cells

(−)-Epigallocatechin-3-Gallate and Quercetin Inhibit Quiescin Sulfhydryl Oxidase 1 Secretion from Hepatocellular Carcinoma Cells

Liver cancer is one of the most prevalent cancers worldwide. The first-line therapeutic drug sorafenib offers only a moderate improvement in patients’ conditions. Therefore, an approach to enhancing its therapeutic efficacy is urgently needed. It has been revealed that hepatocellular carcinoma (HCC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Lumin Yang, Yuying Fang, Yufeng He, Jinsong Zhang
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antioxidants
Subjects:
QSOX1
hepatocellular carcinoma
EGCG
quercetin
sorafenib
secretion
Online Access:https://www.mdpi.com/2076-3921/14/1/106
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items